Hepatitis B and C viruses and hepatocellular carcinoma

Viruses

Volumn 2, Issue 8, 2010, Pages 1504-1509

  Bartosch, Birke ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; INTERFERON; RIBAVIRIN;

ADAPTIVE IMMUNITY; EDITORIAL; GENETIC HETEROGENEITY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INNATE IMMUNITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS CELL TRANSFORMATION; VIRUS LOAD;

EID: 79952121951     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v2081504     Document Type: Editorial

References (16)

1. WHO Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J. Viral. Hepat. 1999, 6, 35-47.
2. Parkin, D.M.; Bray, F.; Ferlay, J.; Pisani, P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94, 153-156.
3. El-Serag, H.B. Epidemiology of hepatocellular carcinoma in USA. Hepatol. Res. 2007, 37 (Suppl. 2), S88-94.
4. El-Serag, H.B.; Rudolph, K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132, 2557-2576.
5. Chang, M.H. Cancer prevention by vaccination against hepatitis B. Recent Results Cancer Res. 2009, 181, 85-94.
6. Si Ahmed, S.N.; Zoulim, F. Pathobiology of HBV mutants and clinical impact for treatment monitoring. Expert Rev. Anti. Infect. Ther. 2009, 7, 309-320.
7. Brechot, C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004, 127, S56-61.
8. Moradpour, D.; Penin, F.; Rice, C.M. Replication of hepatitis C virus. Nat. Rev. Microbiol. 2007, 5, 453-463.
9. Bartosch, B.; Thimme, R.; Blum, H.E.; Zoulim, F. Hepatitis C virus-induced hepatocarcinogenesis. J. Hepatol. 2009, 51, 810-820.
10. Friedman, S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134, 1655-1669
11. McGivern, D.R.; Lemon, S.M. Tumor Suppressors, Chromosomal Instability, and Hepatitis C Virus-Associated Liver Cancer. Annu. Rev. Pathol. 2008.
12. Koike, K. Pathogenesis of HCV-associated HCC: Dual-pass carcinogenesis through activation of oxidative stress and intracellular signaling. Hepatol Res 2007, 37 (Suppl. 2), S115-120.
13. Miyanari, Y.; Atsuzawa, K.; Usuda, N.; Watashi, K.; Hishiki, T.; Zayas, M.; Bartenschlager, R.; Wakita, T.; Hijikata, M.; Shimotohno, K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 2007, 9, 1089-1097.
14. Lindenbach, B.D.; Meuleman, P.; Ploss, A.; Vanwolleghem, T.; Syder, A.J.; McKeating, J.A.; Lanford, R.E.; Feinstone, S.M.; Major, M.E.; Leroux-Roels, G.; Rice, C.M. Cell culture grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 3805-3809.
15. Negro, F.; Clement, S. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C. J. Viral. Hepat. 2009, 16, 681-688.
16. Cabibbo, G.; Craxi, A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur. Rev. Med. Pharmacol. Sci. 2010, 14, 352-355